Выпуск

De-Risking Product Decisions in MedTech Startups with Brent Lavin of Ironwood MedTech Partners

The Med Device Cyber Podcast · 23 апреля 2026 г. · 43 мин

Product decisions made during early development determine commercialization outcomes years later. Wrong choices about regulatory pathways, feature sets, and market segments create compounding problems limiting commercial success. Christian Espinosa and Trevor Slattery explore product management with Brent Lavin, Chief Product Catalyst of Ironwood MedTech Partners, covering why 510(k) pathways average four years while PMA programs require seven to nine years, and how feature set alignment shapes success. The engineering mindset applies hypothesis testing to product development through iterative refinement. Practical for MedTech founders and product teams. Episode Breakdown: 00:02 Introduction 04:35 Ironwood origin 06:02 De-risking decisions 10:15 Hypothesis testing 14:30 Pathway selection 18:45 Timelines 22:20 Claims limits 26:40 Feature alignment 30:15 Segmentation 34:55 Clinical trials 38:45 Entrepreneurship 40:45 Insights 43:29 Close The Med Device Cyber Podcast is brought to you by Blue Goat Cyber, cybersecurity experts providing essential security solutions for the medical device industry. Learn more by visiting https://bluegoatcyber.com . If you're interested in our services or partnering with us, schedule a Discovery Session: https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session Christian Espinosa is the CEO and founder of Blue Goat Cyber. Trevor Slattery is the Chief Operating Officer at Blue Goat Cyber. Christian Espinosa on LinkedIn: https://www.linkedin.com/in/christianespinosa/ Trevor Slattery on LinkedIn: https://www.linkedin.com/in/trevor-slattery-34852b1a9 Blue Goat Cyber on LinkedIn: https://www.linkedin.com/company/blue-goat-cyber/ Blue Goat Cyber on Instagram: https://www.instagram.com/bluegoatcyber/ Blue Goat Cyber on Facebook: https://www.facebook.com/bluegoatcyber/ Blue Goat Cyber on YouTube: https://www.youtube.com/@BlueGoatCyber/?sub_confirmation=1

Страница выпуска